Global Cancer Tumor Profiling Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cancer Tumor Profiling market size was valued at US$ 38550 million in 2023. With growing demand in downstream market, the Cancer Tumor Profiling is forecast to a readjusted size of US$ 78980 million by 2030 with a CAGR of 10.8% during review period.
The research report highlights the growth potential of the global Cancer Tumor Profiling market. Cancer Tumor Profiling are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Tumor Profiling. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Tumor Profiling market.
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
Key Features:
The report on Cancer Tumor Profiling market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Tumor Profiling market. It may include historical data, market segmentation by Type (e.g., Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Tumor Profiling market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Tumor Profiling market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Tumor Profiling industry. This include advancements in Cancer Tumor Profiling technology, Cancer Tumor Profiling new entrants, Cancer Tumor Profiling new investment, and other innovations that are shaping the future of Cancer Tumor Profiling.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Tumor Profiling market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Tumor Profiling product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Tumor Profiling market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Tumor Profiling market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Tumor Profiling market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Tumor Profiling industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Tumor Profiling market.
Market Segmentation:
Cancer Tumor Profiling market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cancer Tumor Profiling market size was valued at US$ 38550 million in 2023. With growing demand in downstream market, the Cancer Tumor Profiling is forecast to a readjusted size of US$ 78980 million by 2030 with a CAGR of 10.8% during review period.
The research report highlights the growth potential of the global Cancer Tumor Profiling market. Cancer Tumor Profiling are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cancer Tumor Profiling. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cancer Tumor Profiling market.
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
Key Features:
The report on Cancer Tumor Profiling market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cancer Tumor Profiling market. It may include historical data, market segmentation by Type (e.g., Next-generation Sequencing (NGS), Polymerase Chain Reaction (PCR)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cancer Tumor Profiling market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cancer Tumor Profiling market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cancer Tumor Profiling industry. This include advancements in Cancer Tumor Profiling technology, Cancer Tumor Profiling new entrants, Cancer Tumor Profiling new investment, and other innovations that are shaping the future of Cancer Tumor Profiling.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cancer Tumor Profiling market. It includes factors influencing customer ' purchasing decisions, preferences for Cancer Tumor Profiling product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cancer Tumor Profiling market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cancer Tumor Profiling market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cancer Tumor Profiling market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cancer Tumor Profiling industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cancer Tumor Profiling market.
Market Segmentation:
Cancer Tumor Profiling market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Next-generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Microarray
- Others
- Personalized Medicine
- Diagnostics
- Biomarker Discovery
- Prognostics
- Research Applications
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qiagen N.V.
- Roche Molecular Systems Inc.
- Abott Molecular
- Illumina Inc.
- NeoGenomics Laboratories
- HTG Molecular Diagnostic
- Genomic Health Inc.
- Hologic Gen-Probe
- BD Biosciences
- Siemens Healthineers
- Claris Life Sciences
- Personal Genome Diagnostics, Inc.
- Perthera, Inc.
- Foundation Medicine, Inc
- V., Strand
- ApoCell
- Contextual Genomics
- Agendia
- GenScript
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Tumor Profiling Market Size 2019-2030
2.1.2 Cancer Tumor Profiling Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Tumor Profiling Segment by Type
2.2.1 Next-generation Sequencing (NGS)
2.2.2 Polymerase Chain Reaction (PCR)
2.2.3 Immunohistochemistry (IHC)
2.2.4 In Situ Hybridization (ISH)
2.2.5 Microarray
2.2.6 Others
2.3 Cancer Tumor Profiling Market Size by Type
2.3.1 Cancer Tumor Profiling Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
2.4 Cancer Tumor Profiling Segment by Application
2.4.1 Personalized Medicine
2.4.2 Diagnostics
2.4.3 Biomarker Discovery
2.4.4 Prognostics
2.4.5 Research Applications
2.5 Cancer Tumor Profiling Market Size by Application
2.5.1 Cancer Tumor Profiling Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
3 CANCER TUMOR PROFILING MARKET SIZE BY PLAYER
3.1 Cancer Tumor Profiling Market Size Market Share by Players
3.1.1 Global Cancer Tumor Profiling Revenue by Players (2019-2024)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Tumor Profiling Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER TUMOR PROFILING BY REGIONS
4.1 Cancer Tumor Profiling Market Size by Regions (2019-2024)
4.2 Americas Cancer Tumor Profiling Market Size Growth (2019-2024)
4.3 APAC Cancer Tumor Profiling Market Size Growth (2019-2024)
4.4 Europe Cancer Tumor Profiling Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Tumor Profiling Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Tumor Profiling Market Size by Country (2019-2024)
5.2 Americas Cancer Tumor Profiling Market Size by Type (2019-2024)
5.3 Americas Cancer Tumor Profiling Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Tumor Profiling Market Size by Region (2019-2024)
6.2 APAC Cancer Tumor Profiling Market Size by Type (2019-2024)
6.3 APAC Cancer Tumor Profiling Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Tumor Profiling by Country (2019-2024)
7.2 Europe Cancer Tumor Profiling Market Size by Type (2019-2024)
7.3 Europe Cancer Tumor Profiling Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Tumor Profiling by Region (2019-2024)
8.2 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER TUMOR PROFILING MARKET FORECAST
10.1 Global Cancer Tumor Profiling Forecast by Regions (2025-2030)
10.1.1 Global Cancer Tumor Profiling Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Tumor Profiling Forecast
10.1.3 APAC Cancer Tumor Profiling Forecast
10.1.4 Europe Cancer Tumor Profiling Forecast
10.1.5 Middle East & Africa Cancer Tumor Profiling Forecast
10.2 Americas Cancer Tumor Profiling Forecast by Country (2025-2030)
10.2.1 United States Cancer Tumor Profiling Market Forecast
10.2.2 Canada Cancer Tumor Profiling Market Forecast
10.2.3 Mexico Cancer Tumor Profiling Market Forecast
10.2.4 Brazil Cancer Tumor Profiling Market Forecast
10.3 APAC Cancer Tumor Profiling Forecast by Region (2025-2030)
10.3.1 China Cancer Tumor Profiling Market Forecast
10.3.2 Japan Cancer Tumor Profiling Market Forecast
10.3.3 Korea Cancer Tumor Profiling Market Forecast
10.3.4 Southeast Asia Cancer Tumor Profiling Market Forecast
10.3.5 India Cancer Tumor Profiling Market Forecast
10.3.6 Australia Cancer Tumor Profiling Market Forecast
10.4 Europe Cancer Tumor Profiling Forecast by Country (2025-2030)
10.4.1 Germany Cancer Tumor Profiling Market Forecast
10.4.2 France Cancer Tumor Profiling Market Forecast
10.4.3 UK Cancer Tumor Profiling Market Forecast
10.4.4 Italy Cancer Tumor Profiling Market Forecast
10.4.5 Russia Cancer Tumor Profiling Market Forecast
10.5 Middle East & Africa Cancer Tumor Profiling Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Tumor Profiling Market Forecast
10.5.2 South Africa Cancer Tumor Profiling Market Forecast
10.5.3 Israel Cancer Tumor Profiling Market Forecast
10.5.4 Turkey Cancer Tumor Profiling Market Forecast
10.5.5 GCC Countries Cancer Tumor Profiling Market Forecast
10.6 Global Cancer Tumor Profiling Forecast by Type (2025-2030)
10.7 Global Cancer Tumor Profiling Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Information
11.1.2 Qiagen N.V. Cancer Tumor Profiling Product Offered
11.1.3 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Qiagen N.V. Main Business Overview
11.1.5 Qiagen N.V. Latest Developments
11.2 Roche Molecular Systems Inc.
11.2.1 Roche Molecular Systems Inc. Company Information
11.2.2 Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offered
11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Molecular Systems Inc. Main Business Overview
11.2.5 Roche Molecular Systems Inc. Latest Developments
11.3 Abott Molecular
11.3.1 Abott Molecular Company Information
11.3.2 Abott Molecular Cancer Tumor Profiling Product Offered
11.3.3 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abott Molecular Main Business Overview
11.3.5 Abott Molecular Latest Developments
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Information
11.4.2 Illumina Inc. Cancer Tumor Profiling Product Offered
11.4.3 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Illumina Inc. Main Business Overview
11.4.5 Illumina Inc. Latest Developments
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Information
11.5.2 NeoGenomics Laboratories Cancer Tumor Profiling Product Offered
11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 NeoGenomics Laboratories Main Business Overview
11.5.5 NeoGenomics Laboratories Latest Developments
11.6 HTG Molecular Diagnostic
11.6.1 HTG Molecular Diagnostic Company Information
11.6.2 HTG Molecular Diagnostic Cancer Tumor Profiling Product Offered
11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 HTG Molecular Diagnostic Main Business Overview
11.6.5 HTG Molecular Diagnostic Latest Developments
11.7 Genomic Health Inc.
11.7.1 Genomic Health Inc. Company Information
11.7.2 Genomic Health Inc. Cancer Tumor Profiling Product Offered
11.7.3 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Genomic Health Inc. Main Business Overview
11.7.5 Genomic Health Inc. Latest Developments
11.8 Hologic Gen-Probe
11.8.1 Hologic Gen-Probe Company Information
11.8.2 Hologic Gen-Probe Cancer Tumor Profiling Product Offered
11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Hologic Gen-Probe Main Business Overview
11.8.5 Hologic Gen-Probe Latest Developments
11.9 BD Biosciences
11.9.1 BD Biosciences Company Information
11.9.2 BD Biosciences Cancer Tumor Profiling Product Offered
11.9.3 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BD Biosciences Main Business Overview
11.9.5 BD Biosciences Latest Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Information
11.10.2 Siemens Healthineers Cancer Tumor Profiling Product Offered
11.10.3 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Siemens Healthineers Main Business Overview
11.10.5 Siemens Healthineers Latest Developments
11.11 Claris Life Sciences
11.11.1 Claris Life Sciences Company Information
11.11.2 Claris Life Sciences Cancer Tumor Profiling Product Offered
11.11.3 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Claris Life Sciences Main Business Overview
11.11.5 Claris Life Sciences Latest Developments
11.12 Personal Genome Diagnostics, Inc.
11.12.1 Personal Genome Diagnostics, Inc. Company Information
11.12.2 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offered
11.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Personal Genome Diagnostics, Inc. Main Business Overview
11.12.5 Personal Genome Diagnostics, Inc. Latest Developments
11.13 Perthera, Inc.
11.13.1 Perthera, Inc. Company Information
11.13.2 Perthera, Inc. Cancer Tumor Profiling Product Offered
11.13.3 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Perthera, Inc. Main Business Overview
11.13.5 Perthera, Inc. Latest Developments
11.14 Foundation Medicine, Inc
11.14.1 Foundation Medicine, Inc Company Information
11.14.2 Foundation Medicine, Inc Cancer Tumor Profiling Product Offered
11.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Foundation Medicine, Inc Main Business Overview
11.14.5 Foundation Medicine, Inc Latest Developments
11.15 V., Strand
11.15.1 V., Strand Company Information
11.15.2 V., Strand Cancer Tumor Profiling Product Offered
11.15.3 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 V., Strand Main Business Overview
11.15.5 V., Strand Latest Developments
11.16 ApoCell
11.16.1 ApoCell Company Information
11.16.2 ApoCell Cancer Tumor Profiling Product Offered
11.16.3 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 ApoCell Main Business Overview
11.16.5 ApoCell Latest Developments
11.17 Contextual Genomics
11.17.1 Contextual Genomics Company Information
11.17.2 Contextual Genomics Cancer Tumor Profiling Product Offered
11.17.3 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Contextual Genomics Main Business Overview
11.17.5 Contextual Genomics Latest Developments
11.18 Agendia
11.18.1 Agendia Company Information
11.18.2 Agendia Cancer Tumor Profiling Product Offered
11.18.3 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Agendia Main Business Overview
11.18.5 Agendia Latest Developments
11.19 GenScript
11.19.1 GenScript Company Information
11.19.2 GenScript Cancer Tumor Profiling Product Offered
11.19.3 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 GenScript Main Business Overview
11.19.5 GenScript Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Tumor Profiling Market Size 2019-2030
2.1.2 Cancer Tumor Profiling Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cancer Tumor Profiling Segment by Type
2.2.1 Next-generation Sequencing (NGS)
2.2.2 Polymerase Chain Reaction (PCR)
2.2.3 Immunohistochemistry (IHC)
2.2.4 In Situ Hybridization (ISH)
2.2.5 Microarray
2.2.6 Others
2.3 Cancer Tumor Profiling Market Size by Type
2.3.1 Cancer Tumor Profiling Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
2.4 Cancer Tumor Profiling Segment by Application
2.4.1 Personalized Medicine
2.4.2 Diagnostics
2.4.3 Biomarker Discovery
2.4.4 Prognostics
2.4.5 Research Applications
2.5 Cancer Tumor Profiling Market Size by Application
2.5.1 Cancer Tumor Profiling Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
3 CANCER TUMOR PROFILING MARKET SIZE BY PLAYER
3.1 Cancer Tumor Profiling Market Size Market Share by Players
3.1.1 Global Cancer Tumor Profiling Revenue by Players (2019-2024)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Tumor Profiling Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER TUMOR PROFILING BY REGIONS
4.1 Cancer Tumor Profiling Market Size by Regions (2019-2024)
4.2 Americas Cancer Tumor Profiling Market Size Growth (2019-2024)
4.3 APAC Cancer Tumor Profiling Market Size Growth (2019-2024)
4.4 Europe Cancer Tumor Profiling Market Size Growth (2019-2024)
4.5 Middle East & Africa Cancer Tumor Profiling Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cancer Tumor Profiling Market Size by Country (2019-2024)
5.2 Americas Cancer Tumor Profiling Market Size by Type (2019-2024)
5.3 Americas Cancer Tumor Profiling Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Tumor Profiling Market Size by Region (2019-2024)
6.2 APAC Cancer Tumor Profiling Market Size by Type (2019-2024)
6.3 APAC Cancer Tumor Profiling Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Tumor Profiling by Country (2019-2024)
7.2 Europe Cancer Tumor Profiling Market Size by Type (2019-2024)
7.3 Europe Cancer Tumor Profiling Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Tumor Profiling by Region (2019-2024)
8.2 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2019-2024)
8.3 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER TUMOR PROFILING MARKET FORECAST
10.1 Global Cancer Tumor Profiling Forecast by Regions (2025-2030)
10.1.1 Global Cancer Tumor Profiling Forecast by Regions (2025-2030)
10.1.2 Americas Cancer Tumor Profiling Forecast
10.1.3 APAC Cancer Tumor Profiling Forecast
10.1.4 Europe Cancer Tumor Profiling Forecast
10.1.5 Middle East & Africa Cancer Tumor Profiling Forecast
10.2 Americas Cancer Tumor Profiling Forecast by Country (2025-2030)
10.2.1 United States Cancer Tumor Profiling Market Forecast
10.2.2 Canada Cancer Tumor Profiling Market Forecast
10.2.3 Mexico Cancer Tumor Profiling Market Forecast
10.2.4 Brazil Cancer Tumor Profiling Market Forecast
10.3 APAC Cancer Tumor Profiling Forecast by Region (2025-2030)
10.3.1 China Cancer Tumor Profiling Market Forecast
10.3.2 Japan Cancer Tumor Profiling Market Forecast
10.3.3 Korea Cancer Tumor Profiling Market Forecast
10.3.4 Southeast Asia Cancer Tumor Profiling Market Forecast
10.3.5 India Cancer Tumor Profiling Market Forecast
10.3.6 Australia Cancer Tumor Profiling Market Forecast
10.4 Europe Cancer Tumor Profiling Forecast by Country (2025-2030)
10.4.1 Germany Cancer Tumor Profiling Market Forecast
10.4.2 France Cancer Tumor Profiling Market Forecast
10.4.3 UK Cancer Tumor Profiling Market Forecast
10.4.4 Italy Cancer Tumor Profiling Market Forecast
10.4.5 Russia Cancer Tumor Profiling Market Forecast
10.5 Middle East & Africa Cancer Tumor Profiling Forecast by Region (2025-2030)
10.5.1 Egypt Cancer Tumor Profiling Market Forecast
10.5.2 South Africa Cancer Tumor Profiling Market Forecast
10.5.3 Israel Cancer Tumor Profiling Market Forecast
10.5.4 Turkey Cancer Tumor Profiling Market Forecast
10.5.5 GCC Countries Cancer Tumor Profiling Market Forecast
10.6 Global Cancer Tumor Profiling Forecast by Type (2025-2030)
10.7 Global Cancer Tumor Profiling Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Information
11.1.2 Qiagen N.V. Cancer Tumor Profiling Product Offered
11.1.3 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Qiagen N.V. Main Business Overview
11.1.5 Qiagen N.V. Latest Developments
11.2 Roche Molecular Systems Inc.
11.2.1 Roche Molecular Systems Inc. Company Information
11.2.2 Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offered
11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Molecular Systems Inc. Main Business Overview
11.2.5 Roche Molecular Systems Inc. Latest Developments
11.3 Abott Molecular
11.3.1 Abott Molecular Company Information
11.3.2 Abott Molecular Cancer Tumor Profiling Product Offered
11.3.3 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abott Molecular Main Business Overview
11.3.5 Abott Molecular Latest Developments
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Information
11.4.2 Illumina Inc. Cancer Tumor Profiling Product Offered
11.4.3 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Illumina Inc. Main Business Overview
11.4.5 Illumina Inc. Latest Developments
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Information
11.5.2 NeoGenomics Laboratories Cancer Tumor Profiling Product Offered
11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 NeoGenomics Laboratories Main Business Overview
11.5.5 NeoGenomics Laboratories Latest Developments
11.6 HTG Molecular Diagnostic
11.6.1 HTG Molecular Diagnostic Company Information
11.6.2 HTG Molecular Diagnostic Cancer Tumor Profiling Product Offered
11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 HTG Molecular Diagnostic Main Business Overview
11.6.5 HTG Molecular Diagnostic Latest Developments
11.7 Genomic Health Inc.
11.7.1 Genomic Health Inc. Company Information
11.7.2 Genomic Health Inc. Cancer Tumor Profiling Product Offered
11.7.3 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Genomic Health Inc. Main Business Overview
11.7.5 Genomic Health Inc. Latest Developments
11.8 Hologic Gen-Probe
11.8.1 Hologic Gen-Probe Company Information
11.8.2 Hologic Gen-Probe Cancer Tumor Profiling Product Offered
11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Hologic Gen-Probe Main Business Overview
11.8.5 Hologic Gen-Probe Latest Developments
11.9 BD Biosciences
11.9.1 BD Biosciences Company Information
11.9.2 BD Biosciences Cancer Tumor Profiling Product Offered
11.9.3 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BD Biosciences Main Business Overview
11.9.5 BD Biosciences Latest Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Information
11.10.2 Siemens Healthineers Cancer Tumor Profiling Product Offered
11.10.3 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Siemens Healthineers Main Business Overview
11.10.5 Siemens Healthineers Latest Developments
11.11 Claris Life Sciences
11.11.1 Claris Life Sciences Company Information
11.11.2 Claris Life Sciences Cancer Tumor Profiling Product Offered
11.11.3 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Claris Life Sciences Main Business Overview
11.11.5 Claris Life Sciences Latest Developments
11.12 Personal Genome Diagnostics, Inc.
11.12.1 Personal Genome Diagnostics, Inc. Company Information
11.12.2 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offered
11.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Personal Genome Diagnostics, Inc. Main Business Overview
11.12.5 Personal Genome Diagnostics, Inc. Latest Developments
11.13 Perthera, Inc.
11.13.1 Perthera, Inc. Company Information
11.13.2 Perthera, Inc. Cancer Tumor Profiling Product Offered
11.13.3 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Perthera, Inc. Main Business Overview
11.13.5 Perthera, Inc. Latest Developments
11.14 Foundation Medicine, Inc
11.14.1 Foundation Medicine, Inc Company Information
11.14.2 Foundation Medicine, Inc Cancer Tumor Profiling Product Offered
11.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Foundation Medicine, Inc Main Business Overview
11.14.5 Foundation Medicine, Inc Latest Developments
11.15 V., Strand
11.15.1 V., Strand Company Information
11.15.2 V., Strand Cancer Tumor Profiling Product Offered
11.15.3 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 V., Strand Main Business Overview
11.15.5 V., Strand Latest Developments
11.16 ApoCell
11.16.1 ApoCell Company Information
11.16.2 ApoCell Cancer Tumor Profiling Product Offered
11.16.3 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 ApoCell Main Business Overview
11.16.5 ApoCell Latest Developments
11.17 Contextual Genomics
11.17.1 Contextual Genomics Company Information
11.17.2 Contextual Genomics Cancer Tumor Profiling Product Offered
11.17.3 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Contextual Genomics Main Business Overview
11.17.5 Contextual Genomics Latest Developments
11.18 Agendia
11.18.1 Agendia Company Information
11.18.2 Agendia Cancer Tumor Profiling Product Offered
11.18.3 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Agendia Main Business Overview
11.18.5 Agendia Latest Developments
11.19 GenScript
11.19.1 GenScript Company Information
11.19.2 GenScript Cancer Tumor Profiling Product Offered
11.19.3 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 GenScript Main Business Overview
11.19.5 GenScript Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Cancer Tumor Profiling Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Next-generation Sequencing (NGS)
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Immunohistochemistry (IHC)
Table 5. Major Players of In Situ Hybridization (ISH)
Table 6. Major Players of Microarray
Table 7. Major Players of Others
Table 8. Cancer Tumor Profiling Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 11. Cancer Tumor Profiling Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 14. Global Cancer Tumor Profiling Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Cancer Tumor Profiling Revenue Market Share by Player (2019-2024)
Table 16. Cancer Tumor Profiling Key Players Head office and Products Offered
Table 17. Cancer Tumor Profiling Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cancer Tumor Profiling Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Cancer Tumor Profiling Market Size Market Share by Regions (2019-2024)
Table 22. Global Cancer Tumor Profiling Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Cancer Tumor Profiling Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Cancer Tumor Profiling Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Cancer Tumor Profiling Market Size Market Share by Country (2019-2024)
Table 26. Americas Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 28. Americas Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 30. APAC Cancer Tumor Profiling Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Cancer Tumor Profiling Market Size Market Share by Region (2019-2024)
Table 32. APAC Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 34. APAC Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 36. Europe Cancer Tumor Profiling Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Cancer Tumor Profiling Market Size Market Share by Country (2019-2024)
Table 38. Europe Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 40. Europe Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Cancer Tumor Profiling Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Cancer Tumor Profiling
Table 49. Key Market Challenges & Risks of Cancer Tumor Profiling
Table 50. Key Industry Trends of Cancer Tumor Profiling
Table 51. Global Cancer Tumor Profiling Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Cancer Tumor Profiling Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Cancer Tumor Profiling Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Cancer Tumor Profiling Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Qiagen N.V. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 56. Qiagen N.V. Cancer Tumor Profiling Product Offered
Table 57. Qiagen N.V. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Qiagen N.V. Main Business
Table 59. Qiagen N.V. Latest Developments
Table 60. Roche Molecular Systems Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 61. Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offered
Table 62. Roche Molecular Systems Inc. Main Business
Table 63. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Roche Molecular Systems Inc. Latest Developments
Table 65. Abott Molecular Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 66. Abott Molecular Cancer Tumor Profiling Product Offered
Table 67. Abott Molecular Main Business
Table 68. Abott Molecular Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Abott Molecular Latest Developments
Table 70. Illumina Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 71. Illumina Inc. Cancer Tumor Profiling Product Offered
Table 72. Illumina Inc. Main Business
Table 73. Illumina Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Illumina Inc. Latest Developments
Table 75. NeoGenomics Laboratories Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 76. NeoGenomics Laboratories Cancer Tumor Profiling Product Offered
Table 77. NeoGenomics Laboratories Main Business
Table 78. NeoGenomics Laboratories Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. NeoGenomics Laboratories Latest Developments
Table 80. HTG Molecular Diagnostic Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 81. HTG Molecular Diagnostic Cancer Tumor Profiling Product Offered
Table 82. HTG Molecular Diagnostic Main Business
Table 83. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. HTG Molecular Diagnostic Latest Developments
Table 85. Genomic Health Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 86. Genomic Health Inc. Cancer Tumor Profiling Product Offered
Table 87. Genomic Health Inc. Main Business
Table 88. Genomic Health Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Genomic Health Inc. Latest Developments
Table 90. Hologic Gen-Probe Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 91. Hologic Gen-Probe Cancer Tumor Profiling Product Offered
Table 92. Hologic Gen-Probe Main Business
Table 93. Hologic Gen-Probe Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Hologic Gen-Probe Latest Developments
Table 95. BD Biosciences Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 96. BD Biosciences Cancer Tumor Profiling Product Offered
Table 97. BD Biosciences Main Business
Table 98. BD Biosciences Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. BD Biosciences Latest Developments
Table 100. Siemens Healthineers Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 101. Siemens Healthineers Cancer Tumor Profiling Product Offered
Table 102. Siemens Healthineers Main Business
Table 103. Siemens Healthineers Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Siemens Healthineers Latest Developments
Table 105. Claris Life Sciences Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 106. Claris Life Sciences Cancer Tumor Profiling Product Offered
Table 107. Claris Life Sciences Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Claris Life Sciences Main Business
Table 109. Claris Life Sciences Latest Developments
Table 110. Personal Genome Diagnostics, Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 111. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offered
Table 112. Personal Genome Diagnostics, Inc. Main Business
Table 113. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Personal Genome Diagnostics, Inc. Latest Developments
Table 115. Perthera, Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 116. Perthera, Inc. Cancer Tumor Profiling Product Offered
Table 117. Perthera, Inc. Main Business
Table 118. Perthera, Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Perthera, Inc. Latest Developments
Table 120. Foundation Medicine, Inc Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 121. Foundation Medicine, Inc Cancer Tumor Profiling Product Offered
Table 122. Foundation Medicine, Inc Main Business
Table 123. Foundation Medicine, Inc Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Foundation Medicine, Inc Latest Developments
Table 125. V., Strand Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 126. V., Strand Cancer Tumor Profiling Product Offered
Table 127. V., Strand Main Business
Table 128. V., Strand Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. V., Strand Latest Developments
Table 130. ApoCell Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 131. ApoCell Cancer Tumor Profiling Product Offered
Table 132. ApoCell Main Business
Table 133. ApoCell Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. ApoCell Latest Developments
Table 135. Contextual Genomics Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 136. Contextual Genomics Cancer Tumor Profiling Product Offered
Table 137. Contextual Genomics Main Business
Table 138. Contextual Genomics Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Contextual Genomics Latest Developments
Table 140. Agendia Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 141. Agendia Cancer Tumor Profiling Product Offered
Table 142. Agendia Main Business
Table 143. Agendia Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Agendia Latest Developments
Table 145. GenScript Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 146. GenScript Cancer Tumor Profiling Product Offered
Table 147. GenScript Main Business
Table 148. GenScript Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. GenScript Latest Developments
.
Table 1. Cancer Tumor Profiling Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Next-generation Sequencing (NGS)
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Immunohistochemistry (IHC)
Table 5. Major Players of In Situ Hybridization (ISH)
Table 6. Major Players of Microarray
Table 7. Major Players of Others
Table 8. Cancer Tumor Profiling Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 11. Cancer Tumor Profiling Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 14. Global Cancer Tumor Profiling Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Cancer Tumor Profiling Revenue Market Share by Player (2019-2024)
Table 16. Cancer Tumor Profiling Key Players Head office and Products Offered
Table 17. Cancer Tumor Profiling Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cancer Tumor Profiling Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Cancer Tumor Profiling Market Size Market Share by Regions (2019-2024)
Table 22. Global Cancer Tumor Profiling Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Cancer Tumor Profiling Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Cancer Tumor Profiling Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Cancer Tumor Profiling Market Size Market Share by Country (2019-2024)
Table 26. Americas Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 28. Americas Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 30. APAC Cancer Tumor Profiling Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Cancer Tumor Profiling Market Size Market Share by Region (2019-2024)
Table 32. APAC Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 34. APAC Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 36. Europe Cancer Tumor Profiling Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Cancer Tumor Profiling Market Size Market Share by Country (2019-2024)
Table 38. Europe Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 40. Europe Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Cancer Tumor Profiling Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Cancer Tumor Profiling Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Cancer Tumor Profiling Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Cancer Tumor Profiling
Table 49. Key Market Challenges & Risks of Cancer Tumor Profiling
Table 50. Key Industry Trends of Cancer Tumor Profiling
Table 51. Global Cancer Tumor Profiling Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Cancer Tumor Profiling Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Cancer Tumor Profiling Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Cancer Tumor Profiling Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Qiagen N.V. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 56. Qiagen N.V. Cancer Tumor Profiling Product Offered
Table 57. Qiagen N.V. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Qiagen N.V. Main Business
Table 59. Qiagen N.V. Latest Developments
Table 60. Roche Molecular Systems Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 61. Roche Molecular Systems Inc. Cancer Tumor Profiling Product Offered
Table 62. Roche Molecular Systems Inc. Main Business
Table 63. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Roche Molecular Systems Inc. Latest Developments
Table 65. Abott Molecular Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 66. Abott Molecular Cancer Tumor Profiling Product Offered
Table 67. Abott Molecular Main Business
Table 68. Abott Molecular Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Abott Molecular Latest Developments
Table 70. Illumina Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 71. Illumina Inc. Cancer Tumor Profiling Product Offered
Table 72. Illumina Inc. Main Business
Table 73. Illumina Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Illumina Inc. Latest Developments
Table 75. NeoGenomics Laboratories Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 76. NeoGenomics Laboratories Cancer Tumor Profiling Product Offered
Table 77. NeoGenomics Laboratories Main Business
Table 78. NeoGenomics Laboratories Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. NeoGenomics Laboratories Latest Developments
Table 80. HTG Molecular Diagnostic Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 81. HTG Molecular Diagnostic Cancer Tumor Profiling Product Offered
Table 82. HTG Molecular Diagnostic Main Business
Table 83. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. HTG Molecular Diagnostic Latest Developments
Table 85. Genomic Health Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 86. Genomic Health Inc. Cancer Tumor Profiling Product Offered
Table 87. Genomic Health Inc. Main Business
Table 88. Genomic Health Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Genomic Health Inc. Latest Developments
Table 90. Hologic Gen-Probe Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 91. Hologic Gen-Probe Cancer Tumor Profiling Product Offered
Table 92. Hologic Gen-Probe Main Business
Table 93. Hologic Gen-Probe Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Hologic Gen-Probe Latest Developments
Table 95. BD Biosciences Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 96. BD Biosciences Cancer Tumor Profiling Product Offered
Table 97. BD Biosciences Main Business
Table 98. BD Biosciences Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. BD Biosciences Latest Developments
Table 100. Siemens Healthineers Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 101. Siemens Healthineers Cancer Tumor Profiling Product Offered
Table 102. Siemens Healthineers Main Business
Table 103. Siemens Healthineers Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Siemens Healthineers Latest Developments
Table 105. Claris Life Sciences Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 106. Claris Life Sciences Cancer Tumor Profiling Product Offered
Table 107. Claris Life Sciences Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Claris Life Sciences Main Business
Table 109. Claris Life Sciences Latest Developments
Table 110. Personal Genome Diagnostics, Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 111. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product Offered
Table 112. Personal Genome Diagnostics, Inc. Main Business
Table 113. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Personal Genome Diagnostics, Inc. Latest Developments
Table 115. Perthera, Inc. Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 116. Perthera, Inc. Cancer Tumor Profiling Product Offered
Table 117. Perthera, Inc. Main Business
Table 118. Perthera, Inc. Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Perthera, Inc. Latest Developments
Table 120. Foundation Medicine, Inc Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 121. Foundation Medicine, Inc Cancer Tumor Profiling Product Offered
Table 122. Foundation Medicine, Inc Main Business
Table 123. Foundation Medicine, Inc Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Foundation Medicine, Inc Latest Developments
Table 125. V., Strand Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 126. V., Strand Cancer Tumor Profiling Product Offered
Table 127. V., Strand Main Business
Table 128. V., Strand Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. V., Strand Latest Developments
Table 130. ApoCell Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 131. ApoCell Cancer Tumor Profiling Product Offered
Table 132. ApoCell Main Business
Table 133. ApoCell Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. ApoCell Latest Developments
Table 135. Contextual Genomics Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 136. Contextual Genomics Cancer Tumor Profiling Product Offered
Table 137. Contextual Genomics Main Business
Table 138. Contextual Genomics Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Contextual Genomics Latest Developments
Table 140. Agendia Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 141. Agendia Cancer Tumor Profiling Product Offered
Table 142. Agendia Main Business
Table 143. Agendia Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Agendia Latest Developments
Table 145. GenScript Details, Company Type, Cancer Tumor Profiling Area Served and Its Competitors
Table 146. GenScript Cancer Tumor Profiling Product Offered
Table 147. GenScript Main Business
Table 148. GenScript Cancer Tumor Profiling Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. GenScript Latest Developments
LIST OF FIGURES
.
Figure 1. Cancer Tumor Profiling Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Tumor Profiling Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Tumor Profiling Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Tumor Profiling Sales Market Share by Country/Region (2023)
Figure 8. Cancer Tumor Profiling Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Tumor Profiling Market Size Market Share by Type in 2023
Figure 10. Cancer Tumor Profiling in Personalized Medicine
Figure 11. Global Cancer Tumor Profiling Market: Personalized Medicine (2019-2024) & ($ Millions)
Figure 12. Cancer Tumor Profiling in Diagnostics
Figure 13. Global Cancer Tumor Profiling Market: Diagnostics (2019-2024) & ($ Millions)
Figure 14. Cancer Tumor Profiling in Biomarker Discovery
Figure 15. Global Cancer Tumor Profiling Market: Biomarker Discovery (2019-2024) & ($ Millions)
Figure 16. Cancer Tumor Profiling in Prognostics
Figure 17. Global Cancer Tumor Profiling Market: Prognostics (2019-2024) & ($ Millions)
Figure 18. Cancer Tumor Profiling in Research Applications
Figure 19. Global Cancer Tumor Profiling Market: Research Applications (2019-2024) & ($ Millions)
Figure 20. Global Cancer Tumor Profiling Market Size Market Share by Application in 2023
Figure 21. Global Cancer Tumor Profiling Revenue Market Share by Player in 2023
Figure 22. Global Cancer Tumor Profiling Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 24. APAC Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 25. Europe Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 27. Americas Cancer Tumor Profiling Value Market Share by Country in 2023
Figure 28. United States Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Cancer Tumor Profiling Market Size Market Share by Region in 2023
Figure 33. APAC Cancer Tumor Profiling Market Size Market Share by Type in 2023
Figure 34. APAC Cancer Tumor Profiling Market Size Market Share by Application in 2023
Figure 35. China Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Cancer Tumor Profiling Market Size Market Share by Country in 2023
Figure 42. Europe Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Figure 43. Europe Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Figure 44. Germany Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 58. APAC Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 59. Europe Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 61. United States Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 62. Canada Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 65. China Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 66. Japan Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 67. Korea Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 69. India Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 70. Australia Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 71. Germany Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 72. France Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 73. UK Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 74. Italy Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 75. Russia Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 76. Spain Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 79. Israel Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 82. Global Cancer Tumor Profiling Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Cancer Tumor Profiling Market Size Market Share Forecast by Application (2025-2030)
.
Figure 1. Cancer Tumor Profiling Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Tumor Profiling Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cancer Tumor Profiling Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cancer Tumor Profiling Sales Market Share by Country/Region (2023)
Figure 8. Cancer Tumor Profiling Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cancer Tumor Profiling Market Size Market Share by Type in 2023
Figure 10. Cancer Tumor Profiling in Personalized Medicine
Figure 11. Global Cancer Tumor Profiling Market: Personalized Medicine (2019-2024) & ($ Millions)
Figure 12. Cancer Tumor Profiling in Diagnostics
Figure 13. Global Cancer Tumor Profiling Market: Diagnostics (2019-2024) & ($ Millions)
Figure 14. Cancer Tumor Profiling in Biomarker Discovery
Figure 15. Global Cancer Tumor Profiling Market: Biomarker Discovery (2019-2024) & ($ Millions)
Figure 16. Cancer Tumor Profiling in Prognostics
Figure 17. Global Cancer Tumor Profiling Market: Prognostics (2019-2024) & ($ Millions)
Figure 18. Cancer Tumor Profiling in Research Applications
Figure 19. Global Cancer Tumor Profiling Market: Research Applications (2019-2024) & ($ Millions)
Figure 20. Global Cancer Tumor Profiling Market Size Market Share by Application in 2023
Figure 21. Global Cancer Tumor Profiling Revenue Market Share by Player in 2023
Figure 22. Global Cancer Tumor Profiling Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 24. APAC Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 25. Europe Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Cancer Tumor Profiling Market Size 2019-2024 ($ Millions)
Figure 27. Americas Cancer Tumor Profiling Value Market Share by Country in 2023
Figure 28. United States Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Cancer Tumor Profiling Market Size Market Share by Region in 2023
Figure 33. APAC Cancer Tumor Profiling Market Size Market Share by Type in 2023
Figure 34. APAC Cancer Tumor Profiling Market Size Market Share by Application in 2023
Figure 35. China Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Cancer Tumor Profiling Market Size Market Share by Country in 2023
Figure 42. Europe Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Figure 43. Europe Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Figure 44. Germany Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Cancer Tumor Profiling Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Cancer Tumor Profiling Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 58. APAC Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 59. Europe Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 61. United States Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 62. Canada Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 65. China Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 66. Japan Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 67. Korea Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 69. India Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 70. Australia Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 71. Germany Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 72. France Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 73. UK Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 74. Italy Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 75. Russia Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 76. Spain Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 79. Israel Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Cancer Tumor Profiling Market Size 2025-2030 ($ Millions)
Figure 82. Global Cancer Tumor Profiling Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Cancer Tumor Profiling Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Esophogeal Stethoscopes Market Growth 2024-2030
US$ 3,660.00
November 2024
134 pages
Global Micro-Invasive Glaucoma Implants Market Growth 2023-2029
US$ 3,660.00
March 2023
113 pages
Global Kidney Disease Drugs Market Growth 2023-2029
US$ 3,660.00
March 2023
114 pages
Global Essential Oils and Plant Extracts for Livestock Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
85 pages
Global Bupivacaine Injection Market Growth 2023-2029
US$ 3,660.00
February 2023
106 pages
